190 related articles for article (PubMed ID: 34620536)
1. Botulinum toxin type A injections for masticatory muscles hypertrophy: A systematic review.
Rauso R; Lo Giudice G; Tartaro G; Zerbinati N; Nicoletti GF; Fragola R
J Craniomaxillofac Surg; 2022 Jan; 50(1):7-18. PubMed ID: 34620536
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin for masseter hypertrophy.
Fedorowicz Z; van Zuuren EJ; Schoones J
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
[TBL] [Abstract][Full Text] [Related]
3. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring.
Kundu N; Kothari R; Shah N; Sandhu S; Tripathy DM; Galadari H; Gold MH; Goldman MP; Kassir M; Schepler H; Grabbe S; Goldust M
J Cosmet Dermatol; 2022 May; 21(5):1849-1856. PubMed ID: 35176198
[TBL] [Abstract][Full Text] [Related]
5. Exploring botulinum toxin's impact on masseter hypertrophy: a randomized, triple-blinded clinical trial.
de Souza Nobre BB; Rezende L; Barbosa Câmara-Souza M; Sanchez-Ayala A; Blass R; Carbone AC; Manso AC; Ernberg M; Christidis N; De la Torre Canales G
Sci Rep; 2024 Jun; 14(1):14522. PubMed ID: 38914688
[TBL] [Abstract][Full Text] [Related]
6. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin for masseter hypertrophy.
Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
[TBL] [Abstract][Full Text] [Related]
8. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
Aydil B; Başaran B; Unsaler S; Süoğlu Y
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A in the management of masseter muscle hypertrophy.
Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative analysis based on three-dimensional stereophotogrammetry in the observation of curative effect of botulinum toxin A on masseter hypertrophy].
Xue Z; Zeng W; Chen Z; Han Y
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):272-5. PubMed ID: 30044570
[TBL] [Abstract][Full Text] [Related]
11. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
[TBL] [Abstract][Full Text] [Related]
12. Prolonging the duration of masseter muscle reduction by adjusting the masticatory movements after the treatment of masseter muscle hypertrophy with botulinum toxin type a injection.
Wei J; Xu H; Dong J; Li Q; Dai C
Dermatol Surg; 2015 Jan; 41 Suppl 1():S101-9. PubMed ID: 25548838
[TBL] [Abstract][Full Text] [Related]
13. A Simple Botulinum Toxin Injection Technique for Masseter Reduction.
Ng ZY; Yang T
Aesthet Surg J; 2021 Nov; 41(12):NP2104-NP2105. PubMed ID: 34223879
[No Abstract] [Full Text] [Related]
14. Botulinum toxin type A treatment for contouring of the lower face.
Park MY; Ahn KY; Jung DS
Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional CT might be a potential evaluation modality in correction of asymmetrical masseter muscle hypertrophy by botulinum toxin injection.
No YA; Ahn BH; Kim BJ; Kim MN; Hong CK
J Cosmet Laser Ther; 2016; 18(2):113-5. PubMed ID: 26073120
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
Shome D; Khare S; Kapoor R
Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for Botulinum Neurotoxin Injection for Facial Contouring.
Yi KH; Lee HJ; Hur HW; Seo KK; Kim HJ
Plast Reconstr Surg; 2022 Sep; 150(3):562e-571e. PubMed ID: 35759641
[TBL] [Abstract][Full Text] [Related]
19. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
Nilesh K; Dharamsi R; Patil P; Mate P
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
[TBL] [Abstract][Full Text] [Related]
20. Assessment of changes in masseter muscle by three-dimensional close-range photogrammetry after Botulinum toxin type-A injection: A case report with review of literature.
Bayrak NB; Zeybek M; Sanlioglu I; Dolanmaz D
J Pak Med Assoc; 2019 Mar; 69(3):418-422. PubMed ID: 30890839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
